SlideShare una empresa de Scribd logo
1 de 51
Descargar para leer sin conexión
Dr Sariu Ali Didi
Medical Officer, IGMH
Supervisor Dr Ahmed Migdhaadh
Consultant in Internal medicine
ACUTE
PULMONARY EMBOLISM
DVT : Blood clot formation with in
the large veins usually in the legs
PE results from DVTs that have
broken off and travelled to
pulmonary arterial circulation
50 % with pelvic vein or proximal leg
DVT develop PE
Other causes : Air, Amniotic Fluid,
Fat Embolism
Venous thromboembolism
 DVT
 Pulmonary Embolism
Why is it important?
PE is the most common preventable cause of death in
hospitalized patients
Untreated mortality - 30%
80% of pulmonary emboli occur without prior
warning signs or symptoms
Diagnosis can be difficult
Early treatment is highly effective
Hypercoagulability
Hereditary Deficiencies:
Antithrombin deficiency
Protein C deficiency
Protein S deficiency
Factor V Leiden
Prothrombin gene
mutation
Dysfibrinogenemia
Acquired:
Cancer
Pregnancy & postpartum
period
Oral contraceptives
Hormone replacement
therapy
Polycythemia rubravera
Smoking
Anti phospholipid syndrome
Chemotherapy
Stasis
Immobility/cast/travel
Advanced age
Acute medical illness
Major surgery
Spinal cord injury
Obesity
Endothelial Damage
Major surgery
Trauma
Central venous
catheterization
Risk for thromboembolism approximately doubles for each decade beyond
age 60 years
Risk factors
Major Risk (RR 5-20)
• Major and abdominal surgery
• Lower Limb Orthopedic Surgery
• Obstetric – Late preganancy,
LSCS, Pre eclampsia
• Maliganancy- Pelvic , abdominal
or metastatic
• Lower Leg # , varicose veins
• History of proven VTE
Minor Risk Factors ( RR
CVS : HF, HTN, Congenital Heart
Disease, Central lines
Estrogen : OCP, HRT
Others : Occult malignancy, COPD
Neurological disability, obesity,
thrombotic mayeloproliferative
disease, nephrotic syndrome
Inflammatory bowel disease
Risk factors
Acute Pulmonary Embolism
•2001 study : 135.29 million passengers
•4.8 case / million > 10,000 Km
•1.5case /million - 5ooo – 10,000km
•0.01 /million < 5000km
•Watching TV equal time pose less risk ; Air Quality
might have an effect
•Risk increases by ~18% for each 2 hrs increment in a
trip
Economy Class Syndrome ??
Acute Pulmonary Embolism
Non-Specific!!
Diagnosis
Clinical Assessment
•Validated prediction rules standardize clinical
judgement
• Wells
• Geneva
•Assessment of PE pretest probability (low,
intermediate, or high) and hemodynamic status is
essential to guide additional cost-effective evaluation
and may aid in the interpretation of subsequent
tests.
Diagnosis-Probability Assessment
Proportion with PE
65%
30
10%
Acute Pulmonary Embolism
D-Dimer
 Fibrin degradation product
 ELISA tests are highly sensitive (>95%)
 Non specific (~40%): cancer, sepsis, inflammation increase d-
dimer levels
Negative D dimer with Low clinical Probability is sufficient to
exclude PE : 92% sensitive
Raised D- dimer does not imply VTE ( negative predictive value )
D dimer should not be done if clinical probability is high
Biomarker Assays
Chest X-Ray
Study of 2,322 patients with PE:
 Cardiac enlargement (27%)
 Normal (24%)
 Pleural effusion (23%)
 Elevated hemidiaphragm (20%)
 Pulmonary artery enlargement (19%)
 Atelectasis (18%)
 Parenchymal pulmonary infiltrates (17%)
•Usually abnormal, but non-specific most
useful for excluding other conditions.
Chest Radiographs in Acute Pulmonary Embolism: Results From the International Cooperative Pulmonary Embolism Registry. Chest July
2000 118:3338; 10.1378/chest.118.1.33
Westermark sign ?
Hampton hump ?
Hampton hump : a peripheral conical density with
the base apposed to the chest wall
more specific but are not commonly seen
Acute Pulmonary Embolism
The Westermark sign : focal oligemia distal
to a PE
Sinus Tachycardia – Most common
RV strain patterns suggest severe PE
•Inverted T waves V1-V4
•QR in V1
•Incomplete RBBB
•S1Q3T3
ECG
S1Q3T3 and T wave changes
CT angiography (CTA), using a multidetector
spiral scanning system
•primary diagnostic method for suspected PE
•the sensitivity and specificity for detection PE > 90%
•provide clues to possible alternative diagnoses in
patients with symptom consistent with PE
BUT…
•Dye load and large radiation dose
Acute Pulmonary Embolism
• V /Q lung scanning remains an option and can be used
when CTA is not available or is contraindicated.
V /Q Scan
Advantages
 relatively low radiation dose
 no requirement for contrast dye
Limitations
 Unreliable in pts with COPD and
other conditions in which there is
structural Lung disease
 When holding breath is difficult.
• V /Q scanning is most useful in patients with normal
cardiopulmonary status prior-to the acute illness
• Interpretation of V/Q scanning is highly dependent 0n the
pretest likelihood of the presence of PE.
• The sensitivity may range from 50% to 98% and specificity
from 20% to 60%.
• The highest specificity is attained with multiple Large (lobar
or segmental) perfusion defects without anatomically
matching ventilation abnormalities.
• Normal results effectively exclude PE; multiple, large,
mismatched results in the setting of high pretest probability
confirm PE.
compression ultrasonography of the legs
• useful in situation in which dye or radiation exposure is
undesirable (for example, dye allergy or pregnancy,
respectively)
lf DVT is identified : Therapy should be initiated for DVT and the
presumed PE because treatment for both conditions is similar
• If no DVT is identified - chest imaging will be needed
• If diagnosis of PE is initially made with chest imaging (CT or V
/Q scanning) - lower extremity USG is not necessary.
• Used less often
• Confirmation or indeterminate cases
• Invasive
Pulmonary Angiography
Acute Pulmonary Embolism
Risk Stratification
•PE can be stratified into several levels of risk
of early death risk markers.
•Immediate bedside clinical assessment for the
presence or absence of clinical markers allows
stratification into high-risk and non-high-risk
PE
Acute Pulmonary Embolism
Acute Pulmonary Embolism
• The initial focus of PE treatment is stabilization with assessment of
hemodynamic stability and hypotension.
Anticoagulation: Initiate anticoagulation
immediately and achieve therapeutic levels of
anticoagulation within 24 hours; failure to do
so correlates with an increased risk of clinical
progression and recurrence.
Acute Treatment
Hemodynamically Stable Patient
Acute Pulmonary Embolism
Warfarin is generally begun at the time one of
the IV/S/C anticoagulants is started
Overlapping therapy with warfarin and one of
the IV or s/c agents should be continued until a
therapeutic INR is documented for 2 or more
consecutive days
Outpatient VS Inpatient Mx
Hemodynamically stable patients with
normal biomarkers/cardiac ultrasound,
no significant comorbidities (such as cancer, heart
failure,COPD) or need for supplemental oxygen
younger age( <75-80 years)
low risk of anticoagulation complications
ability to adhere to prescribed treatment
• Hemodynamic instability reflects substantial elevation in pulmonary
vascular resistance and pulmonary artery pressure, which compromises
right ventricular function and cardiac output via decreased left ventricular
filling, with consequent decrease in systemic blood pressure.
• Hemodynamically unstable patients usually require supplemental oxygen
and may require mechanical ventilation.
• Fluid resuscitation may improve right ventricular function; however, rapid
fluid infusion may exacerbate pulmonary hypertension and compromise
right ventricular function.
In the setting of otherwise refractory hypotension, vasoconstrictor should
be administered to raise systemic arterial pressure, a key determinant of
coronary blood flow.
Hemodynamically Unstable Patient
•Because of their higher risk for complications
and mortality, patients with refractory
hypotension due to pulmonary embolism
should be treated with thrombolytic therapy,
followed by anticoagulation.
Acute Pulmonary Embolism
Catheter Embolectomy & Fragmentation
An alternative in high-risk PE patients when thrombolysis
is absolutely contraindicated or has failed
Kucher N Chest 2007;132:657-663
Treatment of Acute Pulmonary Embolism
Agnelli G, Becattini C. N Engl J Med 2010;363:266-274
Recurrent PE
or PE and uncured
cancer:
Consider long term
anticoagulation if
benefits>risk
First unprovoked PE:
rx for at least 3-6
months
IVC Filters
•May provide lifelong protection against PE
•Unclear effect on overall survival
• Complications:
•DVT (20%)
•Post thrombotic syndrome (40%)
•IVC thrombosis (30%)
•Consider in pregnant women with extensive
thrombosis
•Optimal duration of retrievable filters is unclear
Poor Prognostic Signs
• Hypotension (not caused by arrhythmia, sepsis, or hypovolemia)
• SBP <90 mm Hg = 53% 90-day all cause mortality
• SBP drop of 40 mm Hg for at least 15 minutes = 15% in–hospital mortality
• Syncope= bad
• Shock= really bad
Poor Prognosis: myocardial injury
•Troponin levels correlate with in-hospital mortality
and clinical course in PE
•Troponins do not necessarily mean “MI”
•Significantly increased mortality in patients with
troponin level >0.1 ng/ml (O.R.= 6)
•Normal troponin has very high NPV (99-100%)
Prognostic value of troponins in acute pulmonary embolism: a meta analysis. Circulation 2007;116:427-
433
Poor Prognosis: myocardial dysfunction
• Brain natriuretic peptide
• Elevated levels related to worse outcomes.
• Low levels can identify patients with a good prognosis (NPV 94-100%)
Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation
2003;107:2545-2547
CT evidence of RV dysfunction
•RV dilation
•RV/LV short axis >1= pulmonary
hypertension
•RV/LV short axis >1.5= severe PE
•Leftward septal bowing
Graph of mean values of the RV/LV ratio relative to clinical outcome.
van der Meer R W et al. Radiology 2005;235:798-803
©2005 by Radiological Society of North America
Transverse contrast-enhanced CT scan shows maximum minor axis measurements of the
right ventricle (A) and left ventricle (B).
van der Meer R W et al. Radiology 2005;235:798-803
©2005 by Radiological Society of North America
Acute Pulmonary Embolism
Acute Pulmonary Embolism
Acute Pulmonary Embolism
Echocardiograms before and after Thrombolysis
Echocardiography-RV Dilation
The key is prevention
• DVT prophylaxis in at-risk patients is quite effective
Questions???

Más contenido relacionado

La actualidad más candente

Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathyHypertrophic cardiomyopathy
Hypertrophic cardiomyopathyFuad Farooq
 
Approach to a patient with Haemoptysis
Approach to a patient with HaemoptysisApproach to a patient with Haemoptysis
Approach to a patient with HaemoptysisKhairul Jessy
 
Refractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device TherapyRefractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device TherapyImran Ahmed
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertensionAbhay Mange
 
Approach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated CardiomyopathyApproach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated CardiomyopathyNizam Uddin
 
Complications of acute mi
Complications of acute miComplications of acute mi
Complications of acute miAmir Mahmoud
 
Pericardial diseases
Pericardial  diseasesPericardial  diseases
Pericardial diseasesikramdr01
 
Acute Coronary Syndrome (NSTEMI)
Acute Coronary Syndrome (NSTEMI) Acute Coronary Syndrome (NSTEMI)
Acute Coronary Syndrome (NSTEMI) Muhammad Asim Rana
 
Pulmonary Embolism
Pulmonary Embolism	Pulmonary Embolism
Pulmonary Embolism Khalid
 
Pulmonary Oedema - Pathophysiology - Approach & Management
Pulmonary Oedema  - Pathophysiology - Approach & ManagementPulmonary Oedema  - Pathophysiology - Approach & Management
Pulmonary Oedema - Pathophysiology - Approach & ManagementArun Vasireddy
 
Current management of atrial fibrillation
Current management of atrial fibrillationCurrent management of atrial fibrillation
Current management of atrial fibrillationMaame Ama Dodd-Glover
 
Idiopathic pulmonary fibrosis copy
Idiopathic pulmonary fibrosis   copyIdiopathic pulmonary fibrosis   copy
Idiopathic pulmonary fibrosis copyAdetunji Adesegun
 
Celphos poisoning
Celphos poisoningCelphos poisoning
Celphos poisoningmohmeet
 
Pulmonary fibrosis
Pulmonary fibrosis   Pulmonary fibrosis
Pulmonary fibrosis Ardra Kurian
 
2019 ESC guidelines on pulmonary embolism
2019 ESC guidelines on pulmonary embolism2019 ESC guidelines on pulmonary embolism
2019 ESC guidelines on pulmonary embolismSaitej Reddy
 

La actualidad más candente (20)

Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathyHypertrophic cardiomyopathy
Hypertrophic cardiomyopathy
 
Atrial Fibrillation by Dr. Aryan
Atrial Fibrillation by Dr. AryanAtrial Fibrillation by Dr. Aryan
Atrial Fibrillation by Dr. Aryan
 
Approach to a patient with Haemoptysis
Approach to a patient with HaemoptysisApproach to a patient with Haemoptysis
Approach to a patient with Haemoptysis
 
Miliary Tuberculosis (dr. mahesh)
Miliary Tuberculosis (dr. mahesh)Miliary Tuberculosis (dr. mahesh)
Miliary Tuberculosis (dr. mahesh)
 
Refractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device TherapyRefractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device Therapy
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
 
Approach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated CardiomyopathyApproach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated Cardiomyopathy
 
Complications of acute mi
Complications of acute miComplications of acute mi
Complications of acute mi
 
Cor pulmonale
Cor pulmonaleCor pulmonale
Cor pulmonale
 
Pericardial diseases
Pericardial  diseasesPericardial  diseases
Pericardial diseases
 
Ards new
Ards newArds new
Ards new
 
Acute Coronary Syndrome (NSTEMI)
Acute Coronary Syndrome (NSTEMI) Acute Coronary Syndrome (NSTEMI)
Acute Coronary Syndrome (NSTEMI)
 
Pulmonary Embolism
Pulmonary Embolism	Pulmonary Embolism
Pulmonary Embolism
 
Pulmonary Oedema - Pathophysiology - Approach & Management
Pulmonary Oedema  - Pathophysiology - Approach & ManagementPulmonary Oedema  - Pathophysiology - Approach & Management
Pulmonary Oedema - Pathophysiology - Approach & Management
 
Current management of atrial fibrillation
Current management of atrial fibrillationCurrent management of atrial fibrillation
Current management of atrial fibrillation
 
Idiopathic pulmonary fibrosis copy
Idiopathic pulmonary fibrosis   copyIdiopathic pulmonary fibrosis   copy
Idiopathic pulmonary fibrosis copy
 
Acute coronary syndromes
Acute coronary syndromesAcute coronary syndromes
Acute coronary syndromes
 
Celphos poisoning
Celphos poisoningCelphos poisoning
Celphos poisoning
 
Pulmonary fibrosis
Pulmonary fibrosis   Pulmonary fibrosis
Pulmonary fibrosis
 
2019 ESC guidelines on pulmonary embolism
2019 ESC guidelines on pulmonary embolism2019 ESC guidelines on pulmonary embolism
2019 ESC guidelines on pulmonary embolism
 

Destacado

Pulmonary embolism ppt
Pulmonary embolism pptPulmonary embolism ppt
Pulmonary embolism pptresmigs
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolismTeleClinEd
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolismAmir Mahmoud
 
Pulmonary Embolism- Diagnosis by Dr.Tinku Joseph
Pulmonary Embolism- Diagnosis  by Dr.Tinku JosephPulmonary Embolism- Diagnosis  by Dr.Tinku Joseph
Pulmonary Embolism- Diagnosis by Dr.Tinku JosephDr.Tinku Joseph
 
Pulmonary embolism,overview
Pulmonary embolism,overviewPulmonary embolism,overview
Pulmonary embolism,overviewEman Mahmoud
 
Management of pulmonary embolism in emergency department
Management of pulmonary embolism in emergency departmentManagement of pulmonary embolism in emergency department
Management of pulmonary embolism in emergency departmentdrbarai
 
Pulmonary Embolism
Pulmonary EmbolismPulmonary Embolism
Pulmonary Embolismcairo1957
 
Pulmonary embolism in Emergency Department v2.0
Pulmonary embolism in Emergency Department v2.0Pulmonary embolism in Emergency Department v2.0
Pulmonary embolism in Emergency Department v2.0drbarai
 
Leptospirosis : update on management
Leptospirosis : update on managementLeptospirosis : update on management
Leptospirosis : update on managementVasif Mayan
 
Pulmonary embolism ms
Pulmonary embolism msPulmonary embolism ms
Pulmonary embolism mscardilogy
 
Deep vein thrombosis and Pulmonary embolism 2014
Deep vein thrombosis and Pulmonary embolism 2014Deep vein thrombosis and Pulmonary embolism 2014
Deep vein thrombosis and Pulmonary embolism 2014Gabi Cismaru
 
Management of IlioFemoral Deep Vein Thrombosis
Management of IlioFemoral Deep Vein ThrombosisManagement of IlioFemoral Deep Vein Thrombosis
Management of IlioFemoral Deep Vein ThrombosisSun Yai-Cheng
 
Síndrome de Embolismo Graso Postraumático
Síndrome de Embolismo Graso PostraumáticoSíndrome de Embolismo Graso Postraumático
Síndrome de Embolismo Graso PostraumáticonAyblancO
 
Deep vein thrombosis and pulmonary embolism in pregnancy
Deep vein thrombosis and pulmonary embolism in pregnancyDeep vein thrombosis and pulmonary embolism in pregnancy
Deep vein thrombosis and pulmonary embolism in pregnancyKahtan Ali
 
Pharmacology Hematologic Drugs
Pharmacology   Hematologic DrugsPharmacology   Hematologic Drugs
Pharmacology Hematologic Drugsjben501
 

Destacado (20)

Pulmonary embolism ppt
Pulmonary embolism pptPulmonary embolism ppt
Pulmonary embolism ppt
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Pulmonary embolism
Pulmonary embolism Pulmonary embolism
Pulmonary embolism
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Pulmonary Embolism- Diagnosis by Dr.Tinku Joseph
Pulmonary Embolism- Diagnosis  by Dr.Tinku JosephPulmonary Embolism- Diagnosis  by Dr.Tinku Joseph
Pulmonary Embolism- Diagnosis by Dr.Tinku Joseph
 
Pulmonary embolism,overview
Pulmonary embolism,overviewPulmonary embolism,overview
Pulmonary embolism,overview
 
Management of pulmonary embolism in emergency department
Management of pulmonary embolism in emergency departmentManagement of pulmonary embolism in emergency department
Management of pulmonary embolism in emergency department
 
Pulmonary Embolism
Pulmonary EmbolismPulmonary Embolism
Pulmonary Embolism
 
Pulmonary embolism in Emergency Department v2.0
Pulmonary embolism in Emergency Department v2.0Pulmonary embolism in Emergency Department v2.0
Pulmonary embolism in Emergency Department v2.0
 
Leptospirosis : update on management
Leptospirosis : update on managementLeptospirosis : update on management
Leptospirosis : update on management
 
Obstetric embolism
Obstetric embolismObstetric embolism
Obstetric embolism
 
Pulmonary embolism ms
Pulmonary embolism msPulmonary embolism ms
Pulmonary embolism ms
 
Deep vein thrombosis and Pulmonary embolism 2014
Deep vein thrombosis and Pulmonary embolism 2014Deep vein thrombosis and Pulmonary embolism 2014
Deep vein thrombosis and Pulmonary embolism 2014
 
Management of IlioFemoral Deep Vein Thrombosis
Management of IlioFemoral Deep Vein ThrombosisManagement of IlioFemoral Deep Vein Thrombosis
Management of IlioFemoral Deep Vein Thrombosis
 
Síndrome de Embolismo Graso Postraumático
Síndrome de Embolismo Graso PostraumáticoSíndrome de Embolismo Graso Postraumático
Síndrome de Embolismo Graso Postraumático
 
Deep vein thrombosis and pulmonary embolism in pregnancy
Deep vein thrombosis and pulmonary embolism in pregnancyDeep vein thrombosis and pulmonary embolism in pregnancy
Deep vein thrombosis and pulmonary embolism in pregnancy
 
Pharmacology Hematologic Drugs
Pharmacology   Hematologic DrugsPharmacology   Hematologic Drugs
Pharmacology Hematologic Drugs
 
Tep pp final
Tep pp final Tep pp final
Tep pp final
 
Snmvflash info n° 2
Snmvflash info n° 2Snmvflash info n° 2
Snmvflash info n° 2
 

Similar a Acute Pulmonary Embolism

ashish pulm embolism.pptx
ashish pulm embolism.pptxashish pulm embolism.pptx
ashish pulm embolism.pptxashishnair22
 
Pulmonary embolism - Diagnosis and management
Pulmonary embolism - Diagnosis and managementPulmonary embolism - Diagnosis and management
Pulmonary embolism - Diagnosis and managementDr Vivek Baliga
 
pulmonary_embolism.ppt
pulmonary_embolism.pptpulmonary_embolism.ppt
pulmonary_embolism.pptKaminiVinathan
 
Pulmonary embolism radiology
Pulmonary embolism radiologyPulmonary embolism radiology
Pulmonary embolism radiologyAnish Choudhary
 
Community acquired pneumonia (cap)
Community acquired pneumonia (cap)Community acquired pneumonia (cap)
Community acquired pneumonia (cap)Naila Ansari
 
Pulmonary embolism 2
Pulmonary embolism 2Pulmonary embolism 2
Pulmonary embolism 2samirelansary
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolismvkatbcd
 
Pulmonary Embolism for Nurses.pptx
Pulmonary Embolism for Nurses.pptxPulmonary Embolism for Nurses.pptx
Pulmonary Embolism for Nurses.pptxAsraf Hussain
 
Pulmonary Embolism & Deep Vein Thrombosis - Handout.pdf
Pulmonary Embolism & Deep Vein Thrombosis - Handout.pdfPulmonary Embolism & Deep Vein Thrombosis - Handout.pdf
Pulmonary Embolism & Deep Vein Thrombosis - Handout.pdfAbdirizakJacda
 
Pulmonary embolism - 2019 ESC Guidelines by Dr. Vaibhav Yawalkar MD DM Cardio...
Pulmonary embolism - 2019 ESC Guidelines by Dr. Vaibhav Yawalkar MD DM Cardio...Pulmonary embolism - 2019 ESC Guidelines by Dr. Vaibhav Yawalkar MD DM Cardio...
Pulmonary embolism - 2019 ESC Guidelines by Dr. Vaibhav Yawalkar MD DM Cardio...vaibhavyawalkar
 
Hemodynamic monitoring- Dr Sandeep Gampa
Hemodynamic monitoring- Dr Sandeep GampaHemodynamic monitoring- Dr Sandeep Gampa
Hemodynamic monitoring- Dr Sandeep GampaSiddharth Pandey
 
Acute Pulmonary Embolism Overview lecture.ppt
Acute Pulmonary Embolism Overview lecture.pptAcute Pulmonary Embolism Overview lecture.ppt
Acute Pulmonary Embolism Overview lecture.pptBasilQuran
 
escpe1-191229130329.pptx
escpe1-191229130329.pptxescpe1-191229130329.pptx
escpe1-191229130329.pptxEastmaMeili1
 
Diagnosis of Pulmonary Embolism - by Dr KD DELE
Diagnosis of Pulmonary Embolism - by Dr KD DELEDiagnosis of Pulmonary Embolism - by Dr KD DELE
Diagnosis of Pulmonary Embolism - by Dr KD DELEKemi Dele-Ijagbulu
 
Revisiting Pulmonary embolism Guidelines
Revisiting Pulmonary embolism GuidelinesRevisiting Pulmonary embolism Guidelines
Revisiting Pulmonary embolism GuidelinesEmad Qasem
 
Pulmonary Embolism (1).ppt
Pulmonary Embolism (1).pptPulmonary Embolism (1).ppt
Pulmonary Embolism (1).pptdeepshikakakoty
 

Similar a Acute Pulmonary Embolism (20)

5 Embolie Pulmonaire.pdf
5 Embolie Pulmonaire.pdf5 Embolie Pulmonaire.pdf
5 Embolie Pulmonaire.pdf
 
ashish pulm embolism.pptx
ashish pulm embolism.pptxashish pulm embolism.pptx
ashish pulm embolism.pptx
 
Pulmonary embolism - Diagnosis and management
Pulmonary embolism - Diagnosis and managementPulmonary embolism - Diagnosis and management
Pulmonary embolism - Diagnosis and management
 
Pulmonary Embolism
Pulmonary Embolism Pulmonary Embolism
Pulmonary Embolism
 
pulmonary_embolism.ppt
pulmonary_embolism.pptpulmonary_embolism.ppt
pulmonary_embolism.ppt
 
Pulmonary embolism radiology
Pulmonary embolism radiologyPulmonary embolism radiology
Pulmonary embolism radiology
 
Community acquired pneumonia (cap)
Community acquired pneumonia (cap)Community acquired pneumonia (cap)
Community acquired pneumonia (cap)
 
Pulmonary embolism 2
Pulmonary embolism 2Pulmonary embolism 2
Pulmonary embolism 2
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Pulmonary Embolism for Nurses.pptx
Pulmonary Embolism for Nurses.pptxPulmonary Embolism for Nurses.pptx
Pulmonary Embolism for Nurses.pptx
 
Pulmonary Embolism & Deep Vein Thrombosis - Handout.pdf
Pulmonary Embolism & Deep Vein Thrombosis - Handout.pdfPulmonary Embolism & Deep Vein Thrombosis - Handout.pdf
Pulmonary Embolism & Deep Vein Thrombosis - Handout.pdf
 
Pulmonary embolism - 2019 ESC Guidelines by Dr. Vaibhav Yawalkar MD DM Cardio...
Pulmonary embolism - 2019 ESC Guidelines by Dr. Vaibhav Yawalkar MD DM Cardio...Pulmonary embolism - 2019 ESC Guidelines by Dr. Vaibhav Yawalkar MD DM Cardio...
Pulmonary embolism - 2019 ESC Guidelines by Dr. Vaibhav Yawalkar MD DM Cardio...
 
Hemodynamic monitoring- Dr Sandeep Gampa
Hemodynamic monitoring- Dr Sandeep GampaHemodynamic monitoring- Dr Sandeep Gampa
Hemodynamic monitoring- Dr Sandeep Gampa
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Acute Pulmonary Embolism Overview lecture.ppt
Acute Pulmonary Embolism Overview lecture.pptAcute Pulmonary Embolism Overview lecture.ppt
Acute Pulmonary Embolism Overview lecture.ppt
 
escpe1-191229130329.pptx
escpe1-191229130329.pptxescpe1-191229130329.pptx
escpe1-191229130329.pptx
 
Diagnosis of Pulmonary Embolism - by Dr KD DELE
Diagnosis of Pulmonary Embolism - by Dr KD DELEDiagnosis of Pulmonary Embolism - by Dr KD DELE
Diagnosis of Pulmonary Embolism - by Dr KD DELE
 
Revisiting Pulmonary embolism Guidelines
Revisiting Pulmonary embolism GuidelinesRevisiting Pulmonary embolism Guidelines
Revisiting Pulmonary embolism Guidelines
 
Pulmonary Embolism (1).ppt
Pulmonary Embolism (1).pptPulmonary Embolism (1).ppt
Pulmonary Embolism (1).ppt
 
Pulmonary Embolism.ppt
Pulmonary Embolism.pptPulmonary Embolism.ppt
Pulmonary Embolism.ppt
 

Más de Sariu Ali

Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease (NAFLD)Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease (NAFLD)Sariu Ali
 
Anemia in CKD
Anemia in CKDAnemia in CKD
Anemia in CKDSariu Ali
 
A Child with Vomiting (problem based approach)
A Child with Vomiting (problem based approach)A Child with Vomiting (problem based approach)
A Child with Vomiting (problem based approach)Sariu Ali
 
CNS tumors and Neuroblastomas
CNS tumors and NeuroblastomasCNS tumors and Neuroblastomas
CNS tumors and NeuroblastomasSariu Ali
 
Malignant Melanoma
Malignant MelanomaMalignant Melanoma
Malignant MelanomaSariu Ali
 
Otological Emergencies
Otological EmergenciesOtological Emergencies
Otological EmergenciesSariu Ali
 

Más de Sariu Ali (7)

Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease (NAFLD)Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease (NAFLD)
 
Anemia in CKD
Anemia in CKDAnemia in CKD
Anemia in CKD
 
A Child with Vomiting (problem based approach)
A Child with Vomiting (problem based approach)A Child with Vomiting (problem based approach)
A Child with Vomiting (problem based approach)
 
CNS tumors and Neuroblastomas
CNS tumors and NeuroblastomasCNS tumors and Neuroblastomas
CNS tumors and Neuroblastomas
 
Malignant Melanoma
Malignant MelanomaMalignant Melanoma
Malignant Melanoma
 
Otological Emergencies
Otological EmergenciesOtological Emergencies
Otological Emergencies
 
Melioidosis
MelioidosisMelioidosis
Melioidosis
 

Último

ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 

Último (20)

ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 

Acute Pulmonary Embolism

  • 1. Dr Sariu Ali Didi Medical Officer, IGMH Supervisor Dr Ahmed Migdhaadh Consultant in Internal medicine ACUTE PULMONARY EMBOLISM
  • 2. DVT : Blood clot formation with in the large veins usually in the legs PE results from DVTs that have broken off and travelled to pulmonary arterial circulation 50 % with pelvic vein or proximal leg DVT develop PE Other causes : Air, Amniotic Fluid, Fat Embolism Venous thromboembolism  DVT  Pulmonary Embolism
  • 3. Why is it important? PE is the most common preventable cause of death in hospitalized patients Untreated mortality - 30% 80% of pulmonary emboli occur without prior warning signs or symptoms Diagnosis can be difficult Early treatment is highly effective
  • 4. Hypercoagulability Hereditary Deficiencies: Antithrombin deficiency Protein C deficiency Protein S deficiency Factor V Leiden Prothrombin gene mutation Dysfibrinogenemia Acquired: Cancer Pregnancy & postpartum period Oral contraceptives Hormone replacement therapy Polycythemia rubravera Smoking Anti phospholipid syndrome Chemotherapy Stasis Immobility/cast/travel Advanced age Acute medical illness Major surgery Spinal cord injury Obesity Endothelial Damage Major surgery Trauma Central venous catheterization Risk for thromboembolism approximately doubles for each decade beyond age 60 years Risk factors
  • 5. Major Risk (RR 5-20) • Major and abdominal surgery • Lower Limb Orthopedic Surgery • Obstetric – Late preganancy, LSCS, Pre eclampsia • Maliganancy- Pelvic , abdominal or metastatic • Lower Leg # , varicose veins • History of proven VTE Minor Risk Factors ( RR CVS : HF, HTN, Congenital Heart Disease, Central lines Estrogen : OCP, HRT Others : Occult malignancy, COPD Neurological disability, obesity, thrombotic mayeloproliferative disease, nephrotic syndrome Inflammatory bowel disease Risk factors
  • 7. •2001 study : 135.29 million passengers •4.8 case / million > 10,000 Km •1.5case /million - 5ooo – 10,000km •0.01 /million < 5000km •Watching TV equal time pose less risk ; Air Quality might have an effect •Risk increases by ~18% for each 2 hrs increment in a trip Economy Class Syndrome ??
  • 10. •Validated prediction rules standardize clinical judgement • Wells • Geneva •Assessment of PE pretest probability (low, intermediate, or high) and hemodynamic status is essential to guide additional cost-effective evaluation and may aid in the interpretation of subsequent tests. Diagnosis-Probability Assessment
  • 13. D-Dimer  Fibrin degradation product  ELISA tests are highly sensitive (>95%)  Non specific (~40%): cancer, sepsis, inflammation increase d- dimer levels Negative D dimer with Low clinical Probability is sufficient to exclude PE : 92% sensitive Raised D- dimer does not imply VTE ( negative predictive value ) D dimer should not be done if clinical probability is high Biomarker Assays
  • 14. Chest X-Ray Study of 2,322 patients with PE:  Cardiac enlargement (27%)  Normal (24%)  Pleural effusion (23%)  Elevated hemidiaphragm (20%)  Pulmonary artery enlargement (19%)  Atelectasis (18%)  Parenchymal pulmonary infiltrates (17%) •Usually abnormal, but non-specific most useful for excluding other conditions. Chest Radiographs in Acute Pulmonary Embolism: Results From the International Cooperative Pulmonary Embolism Registry. Chest July 2000 118:3338; 10.1378/chest.118.1.33 Westermark sign ? Hampton hump ?
  • 15. Hampton hump : a peripheral conical density with the base apposed to the chest wall more specific but are not commonly seen
  • 17. The Westermark sign : focal oligemia distal to a PE
  • 18. Sinus Tachycardia – Most common RV strain patterns suggest severe PE •Inverted T waves V1-V4 •QR in V1 •Incomplete RBBB •S1Q3T3 ECG
  • 19. S1Q3T3 and T wave changes
  • 20. CT angiography (CTA), using a multidetector spiral scanning system •primary diagnostic method for suspected PE •the sensitivity and specificity for detection PE > 90% •provide clues to possible alternative diagnoses in patients with symptom consistent with PE BUT… •Dye load and large radiation dose
  • 22. • V /Q lung scanning remains an option and can be used when CTA is not available or is contraindicated. V /Q Scan Advantages  relatively low radiation dose  no requirement for contrast dye Limitations  Unreliable in pts with COPD and other conditions in which there is structural Lung disease  When holding breath is difficult.
  • 23. • V /Q scanning is most useful in patients with normal cardiopulmonary status prior-to the acute illness • Interpretation of V/Q scanning is highly dependent 0n the pretest likelihood of the presence of PE. • The sensitivity may range from 50% to 98% and specificity from 20% to 60%. • The highest specificity is attained with multiple Large (lobar or segmental) perfusion defects without anatomically matching ventilation abnormalities. • Normal results effectively exclude PE; multiple, large, mismatched results in the setting of high pretest probability confirm PE.
  • 24. compression ultrasonography of the legs • useful in situation in which dye or radiation exposure is undesirable (for example, dye allergy or pregnancy, respectively) lf DVT is identified : Therapy should be initiated for DVT and the presumed PE because treatment for both conditions is similar • If no DVT is identified - chest imaging will be needed • If diagnosis of PE is initially made with chest imaging (CT or V /Q scanning) - lower extremity USG is not necessary.
  • 25. • Used less often • Confirmation or indeterminate cases • Invasive Pulmonary Angiography
  • 27. Risk Stratification •PE can be stratified into several levels of risk of early death risk markers. •Immediate bedside clinical assessment for the presence or absence of clinical markers allows stratification into high-risk and non-high-risk PE
  • 30. • The initial focus of PE treatment is stabilization with assessment of hemodynamic stability and hypotension. Anticoagulation: Initiate anticoagulation immediately and achieve therapeutic levels of anticoagulation within 24 hours; failure to do so correlates with an increased risk of clinical progression and recurrence. Acute Treatment Hemodynamically Stable Patient
  • 32. Warfarin is generally begun at the time one of the IV/S/C anticoagulants is started Overlapping therapy with warfarin and one of the IV or s/c agents should be continued until a therapeutic INR is documented for 2 or more consecutive days
  • 33. Outpatient VS Inpatient Mx Hemodynamically stable patients with normal biomarkers/cardiac ultrasound, no significant comorbidities (such as cancer, heart failure,COPD) or need for supplemental oxygen younger age( <75-80 years) low risk of anticoagulation complications ability to adhere to prescribed treatment
  • 34. • Hemodynamic instability reflects substantial elevation in pulmonary vascular resistance and pulmonary artery pressure, which compromises right ventricular function and cardiac output via decreased left ventricular filling, with consequent decrease in systemic blood pressure. • Hemodynamically unstable patients usually require supplemental oxygen and may require mechanical ventilation. • Fluid resuscitation may improve right ventricular function; however, rapid fluid infusion may exacerbate pulmonary hypertension and compromise right ventricular function. In the setting of otherwise refractory hypotension, vasoconstrictor should be administered to raise systemic arterial pressure, a key determinant of coronary blood flow. Hemodynamically Unstable Patient
  • 35. •Because of their higher risk for complications and mortality, patients with refractory hypotension due to pulmonary embolism should be treated with thrombolytic therapy, followed by anticoagulation.
  • 37. Catheter Embolectomy & Fragmentation An alternative in high-risk PE patients when thrombolysis is absolutely contraindicated or has failed Kucher N Chest 2007;132:657-663
  • 38. Treatment of Acute Pulmonary Embolism Agnelli G, Becattini C. N Engl J Med 2010;363:266-274 Recurrent PE or PE and uncured cancer: Consider long term anticoagulation if benefits>risk First unprovoked PE: rx for at least 3-6 months
  • 39. IVC Filters •May provide lifelong protection against PE •Unclear effect on overall survival • Complications: •DVT (20%) •Post thrombotic syndrome (40%) •IVC thrombosis (30%) •Consider in pregnant women with extensive thrombosis •Optimal duration of retrievable filters is unclear
  • 40. Poor Prognostic Signs • Hypotension (not caused by arrhythmia, sepsis, or hypovolemia) • SBP <90 mm Hg = 53% 90-day all cause mortality • SBP drop of 40 mm Hg for at least 15 minutes = 15% in–hospital mortality • Syncope= bad • Shock= really bad
  • 41. Poor Prognosis: myocardial injury •Troponin levels correlate with in-hospital mortality and clinical course in PE •Troponins do not necessarily mean “MI” •Significantly increased mortality in patients with troponin level >0.1 ng/ml (O.R.= 6) •Normal troponin has very high NPV (99-100%) Prognostic value of troponins in acute pulmonary embolism: a meta analysis. Circulation 2007;116:427- 433
  • 42. Poor Prognosis: myocardial dysfunction • Brain natriuretic peptide • Elevated levels related to worse outcomes. • Low levels can identify patients with a good prognosis (NPV 94-100%) Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003;107:2545-2547
  • 43. CT evidence of RV dysfunction •RV dilation •RV/LV short axis >1= pulmonary hypertension •RV/LV short axis >1.5= severe PE •Leftward septal bowing
  • 44. Graph of mean values of the RV/LV ratio relative to clinical outcome. van der Meer R W et al. Radiology 2005;235:798-803 ©2005 by Radiological Society of North America
  • 45. Transverse contrast-enhanced CT scan shows maximum minor axis measurements of the right ventricle (A) and left ventricle (B). van der Meer R W et al. Radiology 2005;235:798-803 ©2005 by Radiological Society of North America
  • 49. Echocardiograms before and after Thrombolysis Echocardiography-RV Dilation
  • 50. The key is prevention • DVT prophylaxis in at-risk patients is quite effective